In older patients with FLT3-mutated #AML, the addition of #quizartinib to intensive chemotherapy significantly improved overall survival compared with chemotherapy alone at a rate of 47% vs. 25%, in addition to reducing relapse risk: https://ow.ly/4nux50ZOt4m